SLC6A3 and schizophrenia: Contrasting to our findings in BA 10, our data shows lower levels of desmethylimipramine-insensitive mazindol-sensitive [3H]mazindol to DAT in the dorsal putamen and dorsal caudate from patients with schizophrenia.